Clinical Trials Browser

Phase NA × INDUSTRY × Neoplasms, Second Primary × Clear all

NCT06562647 2026-02-13

SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors

Phase NA Recruiting

Ovarian Neoplasms, Neoplasms, Second Primary